Barclays PLC
20 May 2002
20 May 2002
Notification of directors' interests: Companies Act 1985 s.329
1. The trustee of the Barclays Qualifying Employee Share Ownership Trust
(the 'Quest') notified the Company on 17 May 2002 that it subscribed for a total
of 267,400 Barclays PLC ordinary shares on 17 May 2002 at a price of 619p per
share. Following this transaction, the trustee of the Quest held a total of
267,400 Barclays PLC ordinary shares in which the following directors of
Barclays PLC had an interest as potential beneficiaries: Sir Peter Middleton, Mr
M W Barrett, Mr C J Lendrum, Mr J M Stewart and Mr J S Varley. (The Quest is a
trust which distributes shares to employees of the Barclays Group on the
exercise of options granted under the Barclays PLC 1991 SAYE Share Option
Scheme, the Barclays Group SAYE Share Option Scheme and the Woolwich plc
Sharesave Scheme (the 'Schemes')).
The trustee of the Quest also notified the Company on 17 May 2002 that it had
transferred 267,400 Barclays PLC ordinary shares on 17 May 2002 to participants
in the Schemes following the exercise of their options. Following this
transaction, each of the directors listed above ceased to have an interest in
such shares.
2. The independent trustee of the Barclays Group (PSP & ESOS) Trust (the
'PSP & ESOS trust') notified the Company on 17 May 2002 that it had on 13 May
2002 exercised its discretion and released 3,711 ordinary shares in Barclays PLC
at a price of 606p per share to meet tax liabilities. None of the shares
released were in respect of an award made to a director of Barclays PLC.
3. The independent trustee of the Barclays Group (ESAS) Employees' Benefit
Trust (the 'ESAS trust') notified the Company on 20 May 2002 that it had on 15
May 2002 exercised its discretion and released 83,555 ordinary shares in
Barclays PLC at a price of 613p to participants in the Executive Share Award
Scheme ('ESAS'). The participants to whom shares were released are not directors
of Barclays PLC.
The independent trustee of the ESAS trust also notified the Company on 20 May
2002 that it had on 17 May 2002 exercised its discretion and purchased 289,891
ordinary shares in Barclays PLC at a price of 625p per share. None of the
shares purchased were in respect of an award made to a director of Barclays PLC.
4. The independent trustee of the Barclays Group (ESAS) Supplementary
Trust (the 'ESAS Supplementary trust') notified the Company on 20 May 2002 that
it had on 17 May 2002 purchased a total of 12,923 ordinary shares in Barclays
PLC at a price of 625p per share. None of the shares purchased was in respect
of an award made to a director of Barclays PLC.
Following these transactions, the trustees of all the Barclays Group employees'
benefit trusts hold a total of 58,441,781 ordinary shares in Barclays PLC. Sir
Peter Middleton, Mr M W Barrett, Sir Andrew Large, Mr C J Lendrum, Mr J M
Stewart and Mr J S Varley, directors of Barclays PLC, are amongst the potential
beneficiaries under these trusts and are therefore regarded for Companies Act
purposes as being interested in the Barclays PLC ordinary shares.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.